切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2007, Vol. 01 ›› Issue (06) : 202 -205. doi: 10.3877/cma.j.issn.1674-0807.2007.06.004

专家论坛

与乳腺癌发病风险相关的基因多态性研究进展
耿翠芝1, 吴祥德1   
  1. 1.050011 石家庄,河北医科大学第四医院外科
  • 收稿日期:2007-05-08 出版日期:2007-12-01

Advances in the study of gene polymorphism in relation to brast cancer risk

Cui-zhi GENG, Xiang-de WU   

  • Received:2007-05-08 Published:2007-12-01
引用本文:

耿翠芝, 吴祥德. 与乳腺癌发病风险相关的基因多态性研究进展[J/OL]. 中华乳腺病杂志(电子版), 2007, 01(06): 202-205.

Cui-zhi GENG, Xiang-de WU. Advances in the study of gene polymorphism in relation to brast cancer risk[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2007, 01(06): 202-205.

[1]
McPherson K, Steel C M, Dixon J M. ABC of breast diseases,breast cancer-epidemiology, risk factors and genetics. BMJ,2000,321:624 -628.
[2]
Lichtenstein P, Holm N V, Verkasalo P K, et al . Environment and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med,2000,343:78 -83.
[3]
Forsti A, Jin R, Altieri A,et al. Polymorphisms in the KDR and POSTN Genes: Association with Breast Cancer Susceptibility and Prognosis. Breast Cancer Res Treat, 2007, 101:83 - 93.
[4]
徐小乐,靳雅丽,沈月平.CYP1A1 基因多态性与乳腺癌关系的Meta 分析.苏州大学学报(医学版),2005,25:1078-1080.
[5]
Chacko P, Joseph T, Mathew B S, et al. Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome. Mutat Res,2005,581:153 -163.
[6]
Wu A H, Seow A, Arakawa K, et al . HSD17B1 and CYP17 polymorphisms and breast cancer risk among Chinese women in Singapore. Int J Cancer,2003,104:450 -457.
[7]
Baxter S W, Choong D Y H, Eccles D M,et al. Polymorphic variation in CYP19 and the risk of breast cancer. Carcinogenesis,2001,22:347 -349.
[8]
Thyagarajan B, Brott M, Mink P, et al . CYP1B1 and CYP19 gene polymorphisms and breast cancer incidence: no association in the ARIC study. Cancer Lett,2004,207:183 -189.
[9]
Miyoshi Y, Iwao K, Ikeda N, et al . Genetic polymorphism in CYP17 and breast cancer risk in Japanese women. Eur J Cancer,2000,36:2375 -2379.
[10]
Costa S, Pinto D, Pereira D, et al . DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population. Breast Cancer Res Treat,2007,103:209 -217.
[11]
Dufloth R M,Costa S, Schmitt F,et al . DNA repair gene polymorphisms and susceptibility to familial breast cancer in a group of patients from Campinas, Brazil. Genet Mol Res,2005,4:771 -82.
[12]
Scola L, Vaglica M,Crivello A,et al. Cytokine gene polymorphisms and breast cancer susceptibility. Ann N Y Acad Sci,2006,1089:104 -109.
[13]
Matsushita K, Takenouchi T, Shimada H,et al. Strong HLADR antigen expression on cancer cells relates to better prognosis of colorectal cancer patients: Possible involvement of c-myc suppression by interferon-gamma in situ. Cancer Sci,2006,97:57 - 63.
[14]
Kamali sarvestani E,Merat A,Talei A R. Polymorphism in the genes of alpha and beta tumor necrosis factors and gamma interferon among Iranian women with breast cancer. Cancer Lett,2005,223:113 -119.
[1] 洪玮, 叶细容, 刘枝红, 杨银凤, 吕志红. 超声影像组学联合临床病理特征预测乳腺癌新辅助化疗完全病理缓解的价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 571-579.
[2] 刘伟, 牛云峰, 安杰. LINC01232 通过miR-516a-5p/BCL9 轴促进三阴性乳腺癌的恶性进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 330-338.
[3] 杨柳, 宋振川, 王新乐. 乳腺癌改良根治术联合背阔肌复位的临床疗效评估[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 269-273.
[4] 张钊, 骆成玉, 张树琦, 何平, 李旭斌. 不同术式治疗早期乳腺癌的效果及并发症发生率、复发率比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 494-497.
[5] 宋佳, 汪波, 孙凯律, 商江峰, 吴旦平, 肇毅. 吲哚菁绿荧光显影联合亚甲蓝染色在乳腺癌前哨淋巴结活检中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 498-501.
[6] 孙建娜, 孔令军, 任崇禧, 穆坤, 王晓蕊. 266例首诊Ⅳ期乳腺癌手术患者预后分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 502-505.
[7] 唐丹萍, 王萍, 江孟蝶, 杨晓蓉. 自体脂肪移植在乳腺癌术后乳房重建的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 582-585.
[8] 黄程鑫, 陈莉, 刘伊楚, 王水良, 赖晓凤. OPA1 在乳腺癌组织的表达特征及在ER阳性乳腺癌细胞中的生物学功能研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 275-284.
[9] 刘琦, 王守凯, 王帅, 苏雨晴, 马壮, 陈海军, 司丕蕾. 乳腺癌肿瘤内微生物组的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 841-845.
[10] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[11] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[12] 王帅, 张志远, 苏雨晴, 李雯雯, 王守凯, 刘琦, 李文涛. 孟德尔随机化及其在乳腺癌研究中的应用进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 671-676.
[13] 张梦婷, 穷拉姆, 色珍, 李逸群, 德庆旺姆. 西藏地区藏族乳腺癌新辅助化疗的真实世界研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 441-446.
[14] 黄宏山, 陈成彩. 经淋巴管超声造影在乳腺癌前哨淋巴结诊断中的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(04): 411-414.
[15] 赵阳, 肖迎聪, 巨艳, 党晓智, 蔡林利, 薛文欣, 李洋, 肖瑶, 郭妤绮, 宋宏萍. 基于自动乳腺超声的列线图模型早期预测HER-2阳性乳腺癌新辅助化疗病理完全缓解的临床价值[J/OL]. 中华临床医师杂志(电子版), 2024, 18(04): 355-362.
阅读次数
全文


摘要